Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin.
about
Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their MetabolitesCEACAM1 modulates epidermal growth factor receptor--mediated cell proliferationCharacterization, Molecular Docking, and In Vitro Dissolution Studies of Solid Dispersions of 20(S)-Protopanaxadiol.Metabolite 1 of protopanaxadiol-type saponins, an axonal regenerative factor, stimulates teneurin-2 linked by PI3-kinase cascade.Identification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV.The bioactivity of saponins: triterpenoid and steroidal glycosides.Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina.Ginsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cellsGinsenoside Re: Its chemistry, metabolism and pharmacokineticsArdipusilloside-I Metabolites from Human Intestinal Bacteria and Their Antitumor Activity.Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 InteractionsApplication of Scutellariae radix, Gardeniae fructus, and Probiotics to Prevent Salmonella enterica Serovar Choleraesuis Infection in SwineChanges of ginsenoside content by mushroom mycelial fermentation in red ginseng extract.Compound K Attenuates the Development of Atherosclerosis in ApoE(-/-) Mice via LXRα ActivationCompound K induces apoptosis of bladder cancer T24 cells via reactive oxygen species-mediated p38 MAPK pathway.Identification of Target Genes Involved in the Antiproliferative Effect of Enzyme-Modified Ginseng Extract in HepG2 Hepatocarcinoma Cell.Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: a hemodynamics approachPharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extractThe ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock.Target genes involved in antiproliferative effect of modified ginseng extracts in lung cancer A549 cells.Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng.Genotoxicity of Nicotiana tabacum leaves on Helix aspersa.Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.Saponins from Panax japonicus protect against alcohol-induced hepatic injury in mice by up-regulating the expression of GPX3, SOD1 and SOD3.Chemotaxonomic Metabolite Profiling of 62 Indigenous Plant Species and Its Correlation with Bioactivities.Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.Compound K inhibits MMP-1 expression through suppression of c-Src-dependent ERK activation in TNF-α-stimulated dermal fibroblast.Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.Purification and characterization of two novel β-glucosidases fromPenicillium oxalicumand their application in bioactive ginsenoside productionLiquid Chromatography–Mass Spectrometric Analysis of Compound K, a Ginseng Saponin Metabolite, in Rat Plasma
P2860
Q27016631-66EB86D4-34BD-4525-9E13-7AA21B1EE48EQ28116188-112189E6-CD78-4F9D-B853-57A9F9B31685Q31162573-A3C9BAF7-C2FB-4A62-964A-B2FD39E066A0Q33227341-84256B22-8C4C-4E52-AB9B-417824FB9125Q33630182-8B76D850-5A7F-444D-A3C9-6BEB16362308Q34153232-5A7E2A0E-51D4-488D-8934-47E0ABAE49FBQ34180271-2EAB17DE-9FFE-436B-BB78-9E3EB984F0FAQ35019757-D0C501DC-EB32-408B-ABDA-A033854D2EC8Q35290630-0C951464-4E51-4CB6-ADEB-3ECCD9FE6155Q35811907-911EECA6-8991-4143-9353-5EC781908229Q35853683-A5675920-6952-4189-A4EB-7D7773416A7DQ36656035-130D11BB-D37D-46A0-BEF4-1C36A9B9BF49Q36692352-3526FB2D-27EF-49F5-88CC-B7E9B8F7D489Q36860845-9E30C451-32A5-425B-8900-7B363118D9A5Q37134445-2CDE4B0C-0BEA-46CA-A524-C9A2A0C0B141Q37183886-49B4FD6E-4778-4543-B07E-FDAF69048FDDQ37224806-47E2D837-FDB5-42B8-ADFB-DC755EE8B9C2Q37283786-781FE888-6A82-4C71-8CCB-1AFC8C5A98F3Q37303203-1804AB46-266E-4613-B25E-98579BD8BE24Q37568769-E48636B3-BF87-48FE-BC20-24D225206177Q39003240-FF1F9D85-83FA-4B80-89BC-DA5CD7488D7AQ39101221-C66F0178-EE82-4975-92FF-3424133D88D0Q40877695-6A2B2E5C-5345-4E5D-89BA-EA388C6F084BQ41809381-E76F0606-EF66-4CF6-AABE-7E701A512B21Q42265763-D74CDE1A-29B8-4EA7-B194-78DA4910F2C3Q43017080-C56751A9-7378-4D6C-9670-060185C5D247Q46643406-FE864A92-8D4F-4743-B9EF-3DF96CAC5217Q46702722-C4C2F793-EB19-40B2-8C3A-320334B08C40Q53261992-68F93DC0-F894-4774-9EDB-AEF4FDE8922BQ55447240-30B1C513-B055-4B0F-A435-E9B51B05ECD9Q56534369-6CE6A086-A321-49C1-84E4-BDCE3089418AQ58131164-380CA269-9AA7-4074-9810-841061220F26
P2860
Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antitumor activity of a novel ...... cells resistant to cisplatin.
@ast
Antitumor activity of a novel ...... cells resistant to cisplatin.
@en
Antitumor activity of a novel ...... cells resistant to cisplatin.
@nl
type
label
Antitumor activity of a novel ...... cells resistant to cisplatin.
@ast
Antitumor activity of a novel ...... cells resistant to cisplatin.
@en
Antitumor activity of a novel ...... cells resistant to cisplatin.
@nl
prefLabel
Antitumor activity of a novel ...... cells resistant to cisplatin.
@ast
Antitumor activity of a novel ...... cells resistant to cisplatin.
@en
Antitumor activity of a novel ...... cells resistant to cisplatin.
@nl
P2093
P1433
P1476
Antitumor activity of a novel ...... cells resistant to cisplatin.
@en
P2093
P356
10.1016/S0304-3835(99)00188-3
P407
P577
1999-09-01T00:00:00Z